share_log

Morgan Stanley Maintains Equal-Weight on Third Harmonic Bio, Raises Price Target to $7

Benzinga ·  Aug 11, 2023 21:16

Morgan Stanley analyst Michael Ulz maintains Third Harmonic Bio (NASDAQ:THRD) with a Equal-Weight and raises the price target from $5 to $7.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment